Sema4 earnings

Author: zafd

August undefined, 2024

WebEarnings for Sema4 (SMFR) Earnings in 2024 (TTM): -$0.33 B. According to Sema4's latest financial reports the company's current earnings (TTM) are -$0.33 B. In 2024 the company … WebApr 9, 2024 · Trellus Management Company LLC lifted its holdings in shares of Sema4 Holdings Corp. (NASDAQ:SMFR – Get Rating) by 148.4% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 1,100,000 shares of the company’s stock after acquiring an additional 657,100 shares during the period. Trellus …

GeneDx Holding Company Profile: Stock Performance & Earnings

WebMay 2, 2024 · STAMFORD, Conn., May 02, 2024 (GLOBE NEWSWIRE) — Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced it has completed the acquisition of... WebGet more information on how to create a Sema4 account. Email. Password. tierphysiotherapie gießen

Sema4 LinkedIn

WebJan 18, 2024 · Sema4 expects FY22 sales of $215 million - $225 million, implying 23-29% growth excluding revenue associated with COVID-19. Sema4 also expects to result over 350,000 tests in 2024, excluding COVID ... WebAug 16, 2024 · Stamford-headquartered Sema4 announced significant changes to its leadership and workforce following a money-losing second quarter earnings report, with … WebMay 12, 2024 · Sema4 is reaffirming its previously issued full year 2024 pro forma revenue target of $350 million. The company now expects fiscal year 2024 total revenue to be $305-315 million, reflecting the... tierphysiotherapie hennef

Sema4 Strengthens AI-Driven Genomic, Clinical Data Platform ... - Benzinga

Sema4 Announces Preliminary Revenue for the Fourth Quarter and …

WebSema4 is a patient-centered predictive health company and a leader in diagnostic testing. The company is founded on the idea that more information, deeper analysis, and … WebMar 2, 2024 · Sema4 (NASDAQ:SMFR) has a recorded net income of -$245.39 million. SMFR has generated -$0.93 earnings per share over the last four quarters. What is Sema4's EPS … tierphysiotherapie hessenWebNov 14, 2024 · Sema4 is maintaining the previously issued full year and second half 2024 reported revenue guidance of $245-255 million and $154-164 million, respectively. Sema4 … tierphysiotherapie fulda

"WebMay 12, 2024 · Other Ticker Details SMFR Company Name Sema4 Holdings Corp Earnings Call Date 12-05-2024 Time (ET) 16:30:00 Fiscal Quarter Q1 Fiscal Year " - Sema4 earnings

Sema4 earnings

Sema4 Reports Third Quarter 2024 Financial Results and New …

WebMar 13, 2024 · Sema4 A will report earnings from Q4 on March 14. 4 analysts predict losses of $0.184 per share compared to losses of $0.170 per share in the same quarter of the previous year. Wall Street expects ... WebAug 15, 2024 · Earlier today, Sema4 released financial results for the second quarter ended June 30, 2024.

Did you know?

WebSema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and … WebApr 11, 2024 · Sema4 Holdings Corp. (NASDAQ:SMFR) released its quarterly earnings data on Monday, November, 15th. The company reported $0.15 EPS for the quarter, beating …

WebSema4 Holdings Corp’s net profit fell -347.14% since last year same period to $-77.58Mn in the Q3 2024. On a quarterly growth basis, Sema4 Holdings Corp has generated 57.81% … WebNov 15, 2024 · Sema4 expects full year 2024 total revenue to be in the range of $201 million to $204 million. Fourth quarter resulted volume is expected to be in the range of 73,000 to …

WebSema4 Holdings Corp. Class A Common Stock (SMFR) 0 Add to Watchlist Add to Portfolio Quotes SMFR SMFR EARNINGS DATE SMFR Earnings Date Earnings Per Share Estimated … WebMay 2, 2024 · STAMFORD, Conn., May 02, 2024 -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced it has completed the acquisition of GeneDx, LLC (“GeneDx”), a leader in genomic testing and analysis for rare disorders, from OPKO Health, Inc. (Nasdaq: OPK) (“OPKO”).

WebNov 16, 2024 · Sema4 Holdings ( NASDAQ:SMFR) Third Quarter 2024 Results Key Financial Results Revenue: US$83.2m (up 93% from 3Q 2024). Net loss: US$77.6m (down by 337% from US$32.7m profit in 3Q 2024). US$0.20...

WebSema4 Holdings Corp. Class A Common Stock (SMFR) 0 Add to Watchlist Add to Portfolio Quotes SMFR SMFR EARNINGS DATE SMFR Earnings Date Earnings Per Share Estimated … tierphysiotherapie hürthWebJul 18, 2024 · SMFR earnings deck The main data points: Testing volumes +27% ex-Covid Women's Health +23% and oncology +159% Revenue $53.9M vs $64.2M in Q1/21 (+6% from Q4/21) Revenue ex-Covid $50.1M vs $48.3M... tierphysiotherapie flensburgWebMar 13, 2024 · Sema4 ( NASDAQ: WGS) is scheduled to announce Q4 earnings results on Tuesday, March 14th, after market close. The consensus EPS Estimate is -$0.16 (+5.9% … tierphysiotherapie hundWebAug 16, 2024 · August 16, 2024 Stamford-headquartered Sema4 announced significant changes to its leadership and workforce following a money-losing second quarter earnings report, with the departure of company... tierphysiotherapie herten tierphysiotherapie frankenthalWebApr 10, 2024 · Sema4 has lower revenue, but higher earnings than P3 Health Partners. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio; P3 Health Partners: $1.05 billion: 0.04-$270.13 million: N/A: N/A: Sema4: $231.15 million: 0.47-$245.39 million-$0.93-0.31: the martian 2015 chris beckWebApr 10, 2024 · Sema4 Announced the Results of A New Study on Mitochondrial Diseases in Newborns Dec 06 CEO & Director recently bought US$100k worth of stock Nov 30 See more updates Shareholder Returns See full shareholder returns Return vs Industry: WGS underperformed the US Healthcare industry which returned -12.6% over the past year. the martian 2015 extended cut